The US is currently facing a major problem concerning the availability of cancer drugs like carboplatin and cisplatin. The shortage is caused by factory closures, quality concerns, and increased demand for alternative drugs. As a result, patients have to wait longer for treatment and sometimes travel far for it. Around 100,000 US patients are affected by the shortage, and it worries them that they will not get the necessary medication.

The shortage is worsened by the high cost of generic drugs and more people getting cancer. Drug companies prioritize profit and may not make these important medicines. Importing drugs temporarily helps, but we need a long-term solution. Experts suggest the government and private companies work together by setting aside reserves of important medicines and giving incentives to good pharmaceutical companies. This will ensure a stable supply of cancer drugs for patients.